Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gillian D Sanders

Showing results (111-120 of 141) with videos related to

Pageof 15
Sort By:
Evidence Report/Technology Assessment|January 16, 2014
Oral contraceptive use for the primary prevention of ovarian cancerLaura J Havrilesky, Jennifer M Gierisch, Patricia G Moorman, et al.
American Heart Journal|June 25, 2005
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004Sana M Al-Khatib, Gillian D Sanders, Daniel B Mark, et al.
Annals of Internal Medicine|June 3, 2014
Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic reviewSana M Al-Khatib, Nancy M Allen LaPointe, Ranee Chatterjee, et al.
JACC. Heart Failure|October 10, 2024
Cardiac Resynchronization Therapy in Ischemic Versus Nonischemic Cardiomyopathy: Patient-Level Meta-Analysis of 7 Randomized Clinical TrialsSaurabh Sudesh, William T Abraham, John G F Cleland, et al.
JAMA|June 4, 2014
Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%Sana M Al-Khatib, Anne S Hellkamp, Gregg C Fonarow, et al.
Journal of the American Heart Association|July 31, 2024
Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-AnalysisNishkala Shivakumar, Daniel J Friedman, Marat Fudim, et al.
American Heart Journal|November 20, 2023
Benefit of cardiac resynchronization therapy among older patients: A patient-level meta-analysisEmily P Zeitler, Frederik Dalgaard, William T Abraham, et al.
European Journal of Heart Failure|September 6, 2023
Comorbidities and clinical response to cardiac resynchronization therapy: Patient-level meta-analysis from eight clinical trialsMarat Fudim, Frederik Dalgaard, Daniel J Friedman, et al.
Eclinicalmedicine|January 24, 2022
Development and validation of DeciBHAL-US: A novel microsimulation model of hearing loss across the lifespan in the United StatesEthan D Borre, Evan R Myers, Judy R Dubno, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-AnalysisNishkala Shivakumar, Daniel J Friedman, Marat Fudim, et al.
Pageof 15

Showing results (111-120 of 141) with videos related to

Sort By:
Pageof 15
Evidence Report/Technology Assessment|January 16, 2014
Oral contraceptive use for the primary prevention of ovarian cancerLaura J Havrilesky, Jennifer M Gierisch, Patricia G Moorman, et al.
American Heart Journal|June 25, 2005
Implantable cardioverter defibrillators and cardiac resynchronization therapy in patients with left ventricular dysfunction: randomized trial evidence through 2004Sana M Al-Khatib, Gillian D Sanders, Daniel B Mark, et al.
Annals of Internal Medicine|June 3, 2014
Rate- and rhythm-control therapies in patients with atrial fibrillation: a systematic reviewSana M Al-Khatib, Nancy M Allen LaPointe, Ranee Chatterjee, et al.
JACC. Heart Failure|October 10, 2024
Cardiac Resynchronization Therapy in Ischemic Versus Nonischemic Cardiomyopathy: Patient-Level Meta-Analysis of 7 Randomized Clinical TrialsSaurabh Sudesh, William T Abraham, John G F Cleland, et al.
JAMA|June 4, 2014
Association between prophylactic implantable cardioverter-defibrillators and survival in patients with left ventricular ejection fraction between 30% and 35%Sana M Al-Khatib, Anne S Hellkamp, Gregg C Fonarow, et al.
Journal of the American Heart Association|July 31, 2024
Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-AnalysisNishkala Shivakumar, Daniel J Friedman, Marat Fudim, et al.
American Heart Journal|November 20, 2023
Benefit of cardiac resynchronization therapy among older patients: A patient-level meta-analysisEmily P Zeitler, Frederik Dalgaard, William T Abraham, et al.
European Journal of Heart Failure|September 6, 2023
Comorbidities and clinical response to cardiac resynchronization therapy: Patient-level meta-analysis from eight clinical trialsMarat Fudim, Frederik Dalgaard, Daniel J Friedman, et al.
Eclinicalmedicine|January 24, 2022
Development and validation of DeciBHAL-US: A novel microsimulation model of hearing loss across the lifespan in the United StatesEthan D Borre, Evan R Myers, Judy R Dubno, et al.
Medrxiv : the Preprint Server for Health Sciences|July 18, 2023
Outcomes of Cardiac Resynchronization Therapy by New York Heart Association Class: A Patient-Level Meta-AnalysisNishkala Shivakumar, Daniel J Friedman, Marat Fudim, et al.
Pageof 15